The Research Institute of the McGill University Health Centre (RI-MUHC) is the research arm of the MUHC, a large academic hospital network affiliated with McGill University’s Faculty of Medicine and Health Sciences. It focuses on research that spans from basic laboratory science to clinical trials, health services, and population health, with the goal of improving patient care across the lifespan.
RI-MUHC is located in Montreal, Quebec, and is considered one of the largest and most modern biomedical and hospital research centres in North America. It supports roughly 440–500 investigators and about 1,200–1,400 trainees (graduate students and postdocs), placing it among the top research hospital institutes in Canada
The institute is organized into eight multidisciplinary programs that cover a wide spectrum of health topics, including brain and neuroscience, cancer, cardiovascular health, child development, metabolic disorders, infectious diseases and global health, injury repair, and respiratory diseases. These programs are designed to foster collaboration between basic, clinical, and evaluative researchers so that discoveries move more quickly into practice.
RI-MUHC conducts and manages phase I to IV clinical trials across more than 30 therapeutic areas, leveraging its integration with MUHC hospitals. This structure allows research teams to work directly with patient populations, from early-stage experimental therapies through to large late-phase studies that can change clinical guidelines.
The institute hosts master’s, PhD, and postdoctoral trainees who are usually supervised by McGill-appointed investigators and often supported through research grants. For someone with a clinical research or biomedical background, RI-MUHC offers opportunities in lab research, clinical trials coordination, data analysis, and health-services or population-health research within a highly collaborative environment.